Skip to content
★ Sign in to follow
무진

무진메디 Stock: price and insider trades · South Korea

No insider purchase over the last 90 days. The latest, by 윤태종, was filed 27 Nov 2025.

무진메디: what insiders have been doing

Every trade that managers of 무진메디 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. 2 insiders have disclosed 3 filings since 1 November 2025.

Every open-market trade in the period is a purchase: 1 purchase, from 1 insider, and not a single sale. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 major shareholder.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 3 filings, this issuer sits below that mark. Our records for 무진메디 go back to 2021, with 36 purchases and no sales on the open market in total.

The latest purchase dates back some time: it was published 348 days ago, on 27 November 2025.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
44
Thresholds
n/a
Buy Volume
n/a
36 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
김진현1 buy
윤태종1 buy

Financial data

· cache

Last declaration on 9 March 2026
Declarations44 total
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    대량보유자Executives
    0DART
    120,957 sharesKRXDART:20251127000516
    Canonical exit: 19 Feb 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    이사Executives(filed)
    0DART
    6,075 sharesShareKRXDART:20250106000062
    Canonical exit: 6 Apr 2025 (T+90)
  • ▲
    대표이사Executives
    0DART
    ShareKRXDART:20240902000280
    Canonical exit: 19 Nov 2024 (T+90)
  • ▲
    대표이사Executives
    0DART
    ShareKRXDART:20240820000203
    Canonical exit: 10 Nov 2024 (T+90)
  • ▲
    대표이사Executives
    0DART
    ShareKRXDART:20240807000328
    Canonical exit: 29 Oct 2024 (T+90)
  • ▲
    Executives
    0DART
    120,957 sharesKRXDART:20230906000294
    Canonical exit: 29 Nov 2023 (T+90)
  • ▲
    대표이사Executives
    0DART
    ShareKRXDART:20230906000185
    Canonical exit: 29 Nov 2023 (T+90)
  • ▲
    Executives
    0DART
    120,957 sharesKRXDART:20230726000072
    Canonical exit: 17 Oct 2023 (T+90)
  • ▲
    Executives
    0DART
    120,957 sharesKRXDART:20230724000199
    Canonical exit: 17 Oct 2023 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    대표이사Executives(filed)
    0DART
    ShareKRXDART:20220919000067
    Canonical exit: 18 Dec 2022 (T+90)
  • ▲
    대표이사Executives(filed)
    0DART
    ShareKRXDART:20220516000754
    Canonical exit: 14 Aug 2022 (T+90)
  • ▲
    대표이사Executives(filed)
    0DART
    ShareKRXDART:20220516000773
    Canonical exit: 14 Aug 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    120,957 sharesKRXDART:20220516000468
    Canonical exit: 14 Aug 2022 (T+90)
  • ▲
    대표이사Executives(filed)
    0DART
    ShareKRXDART:20220408003149
    Canonical exit: 10 Jul 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    120,957 sharesKRXDART:20220408002170
    Canonical exit: 7 Jul 2022 (T+90)
  • ▲
    대표이사Executives(filed)
    0DART
    ShareKRXDART:20220408002177
    Canonical exit: 7 Jul 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    120,957 sharesKRXDART:20220408002994
    Canonical exit: 7 Jul 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    120,957 sharesKRXDART:20220407001500
    Canonical exit: 6 Jul 2022 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives(filed)
    0DART
    120,957 sharesKRXDART:20220304000116
    Canonical exit: 2 Jun 2022 (T+90)

25 of 44 declarations

About 무진메디

Mujin Medi is a healthcare and pharmaceutical company listed on the XKRX. It specializes in developing innovative medical solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations